(NYSE: ATR) Aptargroup's forecast annual revenue growth rate of 2.39% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.
Aptargroup's revenue in 2024 is $3,487,450,000.On average, 3 Wall Street analysts forecast ATR's revenue for 2024 to be $239,461,450,943, with the lowest ATR revenue forecast at $233,446,709,221, and the highest ATR revenue forecast at $242,543,750,262. On average, 3 Wall Street analysts forecast ATR's revenue for 2025 to be $247,265,629,489, with the lowest ATR revenue forecast at $239,982,319,258, and the highest ATR revenue forecast at $257,872,726,531.
In 2026, ATR is forecast to generate $244,781,041,415 in revenue, with the lowest revenue forecast at $244,780,381,252 and the highest revenue forecast at $244,781,701,578.